Nitric Oxide and Ageing: What the Science Says (and Where PEMF with BEMER Fits In)
Published · 3 min read
Nitric oxide (NO) is a molecule that the body produces naturally and that plays a central role in cardiovascular health: it helps keep blood vessels flexible, supports healthy blood pressure and improves circulation. The problem is that its production declines with age: from the age of 30 to 40, many people already notice a significant drop, which has been linked to fatigue, poorer physical recovery and greater vascular stiffness.
The good news is that there are several ways, backed by studies, to support NO production:
- A diet rich in nitrates (beetroot, spinach, rocket)
- Regular exercise, which stimulates endothelial NO production
- Nasal breathing, since the paranasal sinuses generate NO naturally
- Avoiding frequent use of antiseptic mouthwashes, which can disrupt the oral microbiota responsible for converting nitrates into nitrites
- Moderate sun exposure, which may favour its release in the skin
There is one more method that is talked about far less, and that we apply every day at 360Fitness: stimulation with pulsed electromagnetic fields (PEMF).
The science behind PEMF and nitric oxide
Several studies, from cell research to clinical trials in humans, have found a direct link between PEMF stimulation and NO production:
- Diniz et al., Nitric Oxide, 2002: showed that PEMF stimulates the proliferation of osteoblasts (bone cells) through the nitric oxide pathway: when NO synthesis is blocked, the effect disappears.
- Fitzsimmons et al., Journal of Orthopaedic Research, 2008: found the same mechanism in chondrocytes (cartilage cells).
- Patruno et al., British Journal of Dermatology, 2010: showed that low-frequency electromagnetic fields increase the expression of the enzymes that produce NO (eNOS and iNOS) in skin cells, which is relevant to regeneration and wound healing.
- Strauch, Herman, Dabb, Ignarro and Pilla, Aesthetic Surgery Journal, 2009: a review of the clinical evidence, co-authored by Louis Ignarro, winner of the 1998 Nobel Prize in Medicine precisely for discovering the role of nitric oxide as a cardiovascular signalling molecule.
- Kim et al., Blood Pressure, 2020 (PMID 31394939): the most direct study, a randomised, double-blind clinical trial in people with metabolic syndrome. After 12 weeks of PEMF therapy, the treated group showed more nitric oxide in the blood and better blood pressure, both at rest and during exercise.
Taken together, this evidence suggests that PEMF may be one more tool (alongside diet, exercise and the habits already mentioned) to support NO levels and circulatory health.
One clarification is in order that is rarely made: these studies investigate stimulation by pulsed electromagnetic fields in general, not the specific equipment we use. They are literature on the technology, not on the product. The distinction matters, because a result obtained in cultured osteoblasts or in a cohort with metabolic syndrome does not automatically transfer to a healthy person who books a session at a gym.
Each reference states the design and the population studied, which is exactly the information that lets you judge how far what has been demonstrated goes. How far what has been studied goes and what will happen to a particular person are two different things.
PEMF with BEMER at 360Fitness Barcelona
At 360Fitness we apply this technology with BEMER equipment, a class IIa medical device with CE marking. The PEMF applicators are used together with the B.Box Evo to stimulate blood flow in the small and very small blood vessels (microcirculation), and to relieve certain clinical conditions. The full detail is on our BEMER page and at saludcelular.es.
Sessions are by appointment at our centre in Vallcarca, and the first one is free and with no obligation.
Before you book: classification and contraindications
BEMER is a class IIa medical device with CE marking. Its intended purpose is not set by the centre that applies it: it is assessed by a notified body and set out in the manufacturer's official documentation, which is the only source we cite.
PEMF therapy is contraindicated for:
• People with active medical implants (for example medication pumps, pacemakers or implanted defibrillators).
• Recipients of organ transplants, or of allogeneic cell, bone marrow or stem cell transplants, in combination with immunosuppressive therapy.
The manufacturer describes changes in pulse rate and changes in blood pressure as possible, very rare side effects. The application is intended for people aged 14 and over.
For any medical condition, or if in doubt as to whether any of these circumstances applies, the question is one for your doctor before booking. 360Fitness is not a medical practice and does not offer health advice.
Source: BEMER Int. AG, Instructions for use of the BEMER Therapy System Evo, ref. 2090-2109-764011, V05-01 (PDF, 26 MB, published by the manufacturer). The full document is provided before booking.


